期刊文献+
共找到143篇文章
< 1 2 8 >
每页显示 20 50 100
An efficient and green preparation of 5-aminophosphonate substituted pyrimidine nucleosides under solvent-free conditions 被引量:1
1
作者 Xin Ying Zhang Ying Ying Qu Xue Sen Fan 《Chinese Chemical Letters》 SCIE CAS CSCD 2010年第10期1191-1194,共4页
An environmentally benign and highly efficient one-pot preparation of α-aminophosphonates under solvent-free conditions was developed. By employing this method, 5-aminophosphonate substituted pyrimidine nucleosides w... An environmentally benign and highly efficient one-pot preparation of α-aminophosphonates under solvent-free conditions was developed. By employing this method, 5-aminophosphonate substituted pyrimidine nucleosides were synthesized in good to excellent yields starting from 5-forrnyl-2'-deoxyuridine, aniline and dimethylphosphite. 展开更多
关键词 AMINOPHOSPHONATE 5-Substituted pyrimidine nucleoside Solvent-free reaction Green synthesis
下载PDF
Crystal and Molecular Structure of 2-(2, 6-Dinitro-4-Trifluoromethyl) phenylthio-5, 7-Dimethyl-1,2,4-Triazolo [1, 5-a] Pyrimidine 被引量:1
2
作者 YANG Guang-Fu LU Rong-Jian YANG Hua-Zheng(Institute of Elemento-Organic Chemistry, Nankai University, Tianjin, 300071)WANG Hong-Gen(Central Laboratory of Nankai Univiersity, Tianjin, 300071) 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 1997年第4期298-301,共4页
The crystal structure of the title compound has been determined bysingle crystal X-ray diffraction analysis. C14H9F3N6O4S, Mr = 414. 32, monoclinic,space group P21/n, a=8. 287(3), b= 24. 972(4), c= 8. 617(3)A, β= 108... The crystal structure of the title compound has been determined bysingle crystal X-ray diffraction analysis. C14H9F3N6O4S, Mr = 414. 32, monoclinic,space group P21/n, a=8. 287(3), b= 24. 972(4), c= 8. 617(3)A, β= 108. 36(3)°,V= 1693(2) A3, Z=4, Dx=1. 626 g. cm-3, μ=0. 2481 mm-1; F(000) =840, finalR = 0. 057 and Rw= 0. 057 for 1169 observed reflections [I≥3σ(I)]. The results showthat all ring atoms in the triazolopyrimidinyl moiety were coplanar with strong tensileforce, which might be an important active site. 展开更多
关键词 crystal structure 1 2 4-triazolo[1 5-a]pyrimidine compound biological activity
下载PDF
Coupling Reaction of 4-Chloro-7-H-Pyrrolo[2,3-d]Pyrimidine with 2,3,5-Tri-O-Acetyl-b-D-Ribofuranosyl Chloride 被引量:1
3
作者 Yun Long ZHANG Liang Ren ZHANG +5 位作者 Zhen Jun YANG Ji Mei MIN Li He ZHANG Yang LU Ning Bo GONG Qi Tai ZHENG 《Chinese Chemical Letters》 SCIE CAS CSCD 2001年第5期391-394,共4页
Coupling reaction of 4-chloro-7-H-pyrrolo[2,3-d]pyrimidine with 2,3,5-tri-O-acetyl -β-D-ribofuranosyl chloride under the basic condition was investigated. An abnormal coupling reaction, in which the heterocyclic base... Coupling reaction of 4-chloro-7-H-pyrrolo[2,3-d]pyrimidine with 2,3,5-tri-O-acetyl -β-D-ribofuranosyl chloride under the basic condition was investigated. An abnormal coupling reaction, in which the heterocyclic base attacked at the carbon of 1,2-O-methylidene moiety instead of anomeric carbon of ribose was observed and the structure of products 5a, 5b were identified by NMR and X-Ray diffraction. 展开更多
关键词 Chloropyrrolo[2 3-d]pyrimidine 1-chloro-2 3 5-tri-O-acetyl-D-ribofuranose neigh-boring participation effect X-ray diffraction.
下载PDF
Design, Synthesis, and Hypnotic Activity of Pyrazolo[1 ,5-a] pyrimidine Derivatives
4
作者 SongQingWANG LinFANG +1 位作者 XiuJieLIU KangZHAO 《Chinese Chemical Letters》 SCIE CAS CSCD 2004年第8期885-888,共4页
On the basis of the Zaleplon structure, novel pyrazolo[l,5-a]pyrimidines were designed and prepared for studies on their hypnotic activity. This paper reported the synthesis of twelve new 5-methyl-7-substituted-pyrazo... On the basis of the Zaleplon structure, novel pyrazolo[l,5-a]pyrimidines were designed and prepared for studies on their hypnotic activity. This paper reported the synthesis of twelve new 5-methyl-7-substituted-pyrazolo[1,5-a]pyrimidine-3-carbonitrile derivatives by using simple starting materials such as propane dinitrile and triethyl orthoformate. The structures of the derived target compounds were confirmed by their IR and 1H-NMR spectroscopic data. The preliminary pharmacological evaluations indicated that some compounds showed hypnotic activity, while derivative 1c was the most polent one. 展开更多
关键词 GABA hypnotic drug SYNTHESIS pyrazolo[l 5-a]pyrimidines.
下载PDF
Synthesis and Crystal Structure of Ethyl 3-(4-Chlorophenyl)-3,4-dihydro-6-methyl-4-oxo-2-(pyrrolidin-1-yl)furo[2,3-d]pyrimidine-5-carboxylate 被引量:2
5
作者 胡扬根 徐靖 丁明武 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2009年第6期689-692,共4页
The crystal structure of the title compound ethyl 3-(4-chlorophenyl)-3,4-dihydro-6- methyl-4-oxo-2-(pyrrolidin-1-yl)furo[2,3-d]pyrimidine-5-carboxylate (C20H20ClN3O4, Mr= 401.84) has been prepared and determined... The crystal structure of the title compound ethyl 3-(4-chlorophenyl)-3,4-dihydro-6- methyl-4-oxo-2-(pyrrolidin-1-yl)furo[2,3-d]pyrimidine-5-carboxylate (C20H20ClN3O4, Mr= 401.84) has been prepared and determined by single-crystal X-ray diffraction. The crystal is of monoclinic, space group P21/n with a = 20.6215(9), b = 8.5311(4), c = 21.6886(9) A^°, β = 91.607(1)°, V = 3814.0(3)A^°^3, Z = 8, Dc = 1.400 g/cm^3, F(000) = 1680, μ = 0.233 mm^-1, R = 0.0718 and wR = 0.1545 for 6717 observed reflections with I 〉 2σ(I). X-ray diffraction analysis reveals two crystallographically independent molecules in the asymmetric unit. 展开更多
关键词 crystal structure ethyl 3-(4-ehlorophenyl)-3 4-dihydro-6-methyl-4-oxo-2- (pyrrolidin-1-yl)furo[2 3-d]pyrimidine-5-earboxylate aza-Wittig reaction synthesis
下载PDF
Pathogenesis of congenital pyrimidine 5′ -nucleotidase | deficiency: A study on relationship among erythrocyte morphology, enzyme protein content and activity
6
作者 潘竹林 李津婴 +6 位作者 闵碧荷 黄正霞 王健民 许燕群 龚胜兰 章卫平 张娴 《Journal of Medical Colleges of PLA(China)》 CAS 2003年第1期23-26,共4页
Objective: To further explore the mechanism of congenital pyrimidine 5'-nucleotidase I deficiency. Methods; The samples were collected from the family members of a patient with P5'N- I deficiency. The enzyme a... Objective: To further explore the mechanism of congenital pyrimidine 5'-nucleotidase I deficiency. Methods; The samples were collected from the family members of a patient with P5'N- I deficiency. The enzyme activities were measured by UMP method and the enzyme proteins were quantified by ELISA while the morphology of peripheral blood cells was observed. Results: The enzyme contents reduced as their enzyme activities decreased in the family especially in four members. There was a significant positive correlation(r =0. 955) between the activity and the content of P 5'N- I . The count of the stippling cell was varied in the family. Conclusion.- One of the reasons for congenital P5' N- I deficiency might be the deficiency in the enzyme content. The morphology of peripheral blood erythrocyte may be an assistant diagnotic index. The P5'N- I activities and contents were measured simultaneously may be a effective method in clinic diagnosis. 展开更多
关键词 ERYTHROCYTE pyrimidine 5'-nucleotidase ELISA stippling cell
下载PDF
Synthesis and Crystal Structure of 2-Benzylsulefnyl-3-cyano-5,7-dimethyl-pyrazolo[1,5-a]pyrimidine
7
作者 RENXue-Ling WUChao GAOYing ZOUXiao-Mao YANGHua-Zheng 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 北大核心 2004年第3期267-269,共3页
The title compound, C16H14N4S, has been synthesized by the reaction of pentane-2,4-dione with 5-amino-3-benzylthio-4-cyano-1-H-pyrazole in ethanol, and its crystal structure was determined by X-ray diffraction method.... The title compound, C16H14N4S, has been synthesized by the reaction of pentane-2,4-dione with 5-amino-3-benzylthio-4-cyano-1-H-pyrazole in ethanol, and its crystal structure was determined by X-ray diffraction method. The crystal is of monoclinic, space group P21/n with a = 8.699(3), b = 23.139(9), c = 7.536(3) ? b = 92.400(8), V = 1515.5(10) 3, Z = 4, Mr = 294037, Dc = 1.290 g/cm3, = 0.71073 ? (MoKa) = 0.212 mm-1 and F(000) = 616. The structure was refined to R = 0.0533 and wR = 0.1141 for 2672 unique reflections with Rint = 0.06. The structure is a dimmer linked by intermolecular contact S(1)…HC(8) with the S(1)C(8) distance of 3.875 and the angle of 164.8. 展开更多
关键词 pyrazolo[1 5-a]pyrimidine crystal structure synthesis
下载PDF
SYNTHSIS OF 5-CYANO-2-(4-n-PENTYL-4-BIPHENYLYL)-PYRIMIDINE
8
作者 Yong De LI Fang Fang FANG +2 位作者 Lu Ning HAN Qian WANG Dong Hui SHI Chemistry Dept,of Tsinghua University,Beijing 100084 《Chinese Chemical Letters》 SCIE CAS CSCD 1992年第9期699-702,共4页
Condensation of substituted diethyl-malonates with phenylamidine hydrochloride give liquid crystals with a pyrimidine ring,which then subjeet graup transformation to give the title compound—5-cyano-2-(4-n-peatyl-4-bi... Condensation of substituted diethyl-malonates with phenylamidine hydrochloride give liquid crystals with a pyrimidine ring,which then subjeet graup transformation to give the title compound—5-cyano-2-(4-n-peatyl-4-biphenylyl) pyrimidine in high yield. 展开更多
关键词 pyrimidine n-PENTYL-4-BIPHENYLYL SYNTHSIS OF 5-CYANO-2
下载PDF
药物中间体5-(4-溴苯基)-4,6-二氯嘧啶有关物质和含量分析方法
9
作者 柳毅 张卫 +1 位作者 王文标 高军龙 《广州化工》 CAS 2024年第2期184-186,共3页
建立了5-(4-溴苯基)-4,6-二氯嘧啶高效液相色谱法测定有关物质和含量的分析方法。以自身对照法计算未知杂质含量,按外标法计算已知杂质和主成分含量。使用Waters XBridge■-C_(18)色谱柱,流动相为0.1%磷酸和乙腈,梯度洗脱;检测波长210 n... 建立了5-(4-溴苯基)-4,6-二氯嘧啶高效液相色谱法测定有关物质和含量的分析方法。以自身对照法计算未知杂质含量,按外标法计算已知杂质和主成分含量。使用Waters XBridge■-C_(18)色谱柱,流动相为0.1%磷酸和乙腈,梯度洗脱;检测波长210 nm。已知杂质在0.1~2.0μg·mL^(-1)浓度范围内线性关系良好,平均加样回收率在90%~110%,其RSD小于5%。该方法快速、准确,适用于5-(4-溴苯基)-4,6-二氯嘧啶有关物质和含量分析方法的检测。 展开更多
关键词 5-(4-溴苯基)-4 6-二氯嘧啶 高效液相色谱 自身对照 外标法
下载PDF
Induction of Recombinant Uridine Phosphorylase and Its Application in Biosynthesis of Pyrimidine Nucleosides 被引量:1
10
作者 丁庆豹 欧伶 +3 位作者 魏东芝 魏晓琨 许彦梅 张春艳 《Chinese Journal of Chemical Engineering》 SCIE EI CAS CSCD 2011年第1期122-127,共6页
Recombinant Escherichia coli pUDP,which overexpressed uridine phosphorylase(UPase),was constructed.0.5 mmol·L 1lactose had a similar induction effect as the commonly used inducer IPTG during 2.5-5.5 h of cell g... Recombinant Escherichia coli pUDP,which overexpressed uridine phosphorylase(UPase),was constructed.0.5 mmol·L 1lactose had a similar induction effect as the commonly used inducer IPTG during 2.5-5.5 h of cell growth.The lactose-induced UPase was stable at 50°C.Wet cells of pUDP was used as catalyst to biosynthesize 5-fluorouridine from 30 mmol·L 1uridine and 5-fluorouracil in phosphate buffer(pH 7.0)catalyzed at 50°C for 1.5 h and the yield of 5-fluorouridine was higher than 68%.Under the optimum reaction conditions for production of 5-fluorouridine,5-methyluridine and azauridine were synthesized from uridine by pUDP,the yield was 61.7%and 47.2%respectively.Deoxynucleosides were also synthesized by pUDP,but the yield was only about 20%. 展开更多
关键词 5-fluorouridine LACTOSE uridine phosphorylase pyrimidine nucleoside URIDINE 5-FLUOROURACIL
下载PDF
Synthesis and Crystal Structure of 1-(4-Fluorophenyl)-2-hexylthiobenzo[4,5]-furo[3,2-d]-1,2,4-triazolo[1,5-a]pyrimidin-5(1H)-one 被引量:4
11
作者 胡扬根 杜士明 +1 位作者 李清 丁明武 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2011年第1期75-78,共4页
The crystal structure of the title compound 1-(4-fluorophenyl) -2-hexylthio-benzo [4,5]furo[3,2-d]-1,2,4-triazolo[1,5-a]pyrimidin-5(1H) -one(C23H21FN4O2S,Mr = 436.5) has been prepared and determined by single-cr... The crystal structure of the title compound 1-(4-fluorophenyl) -2-hexylthio-benzo [4,5]furo[3,2-d]-1,2,4-triazolo[1,5-a]pyrimidin-5(1H) -one(C23H21FN4O2S,Mr = 436.5) has been prepared and determined by single-crystal X-ray diffraction. The crystal is of monoclinic,space group P21/n with a = 13.9854(3) ,b = 17.2678(4) ,c = 18.1828(5)A,β = 99.364(2) °,V = 4332.58(18) A^3,Z = 4,Dc = 1.338,F(000) =1824,μ = 0.185 mm^-1,MoKa radiation(λ = 0.71073) ,R = 0.0538 and wR = 0.1162 for 4728 observed reflections with I 〉 2σ(I) . X-ray diffraction analysis reveals the fused rings of benzo[4,5]furo[3,2-d]-1,2,4-triazolo[1,5-a] pyrimidin-5(1H) -one system are nearly coplanar. The crystal packing is mainly stabilized by weak intermolecular C-H···O hydrogen bond and π-π interactions. 展开更多
关键词 SYNTHESIS crystal structure 1-(4-fluorophenyl)-2-hexylthio-benzo[4 5]furo[3 2-d]-1 2 4-triazolo[1 5-a]pyrimidin-5(1H)-one
下载PDF
Synthesis, Crystal Structure and Antiproliferative Activity of 2-(((5-(((5,7-Dimethyl-[1,2,4]triazolo-[1,5-a]pyrimidin-2-yl)thio)methyl)-4-phenyl-4H-1,2,4-triazol-3-yl)thio)methyl)-4Hchromen-4-one Methanol Solvate
12
作者 孙海燕 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2014年第10期1467-1471,共5页
The novel crystal of the title compound 2-(((5-(((5,7-dimethyl-[1,2,4]triazolo-[1, 5-a]-pyrimidin-2-yl)thio)methyl)-4-phenyl-4H-1,2,4-triazol-3-yl)thio)methyl)-4H-chromen-4-one methanol solvate(C27H25N7O3... The novel crystal of the title compound 2-(((5-(((5,7-dimethyl-[1,2,4]triazolo-[1, 5-a]-pyrimidin-2-yl)thio)methyl)-4-phenyl-4H-1,2,4-triazol-3-yl)thio)methyl)-4H-chromen-4-one methanol solvate(C27H25N7O3S2, Mr = 559.66) has been prepared and its structure was determined by single-crystal X-ray diffraction. The crystal belongs to the monocline system, space group P21/c with a = 11.9879(9), b = 14.0743(10), c = 15.9706(11)A, β = 98.509(2)°, V = 2664.9(3)A3, Z = 4, Dc = 1.395 g/cm^3, F(000) = 1168, μ = 0.116 mm-1, MoKa radiation(λ = 0.71073), R = 0.0652, and wR = 0.1425 for 5220 observed reflections with I 〉 2σ(I). X-ray diffraction analyses reveal that the molecule adopts a C-shape. The planes of the benzopyrone and triazolopyrimidine were nearly parallel to each other, with a dihedral angle of 1.21(3)°. Intramolecular and intermolecular hydrogen bonds together with π-π interations are found to exist in the structure. The results of MTT assay indicate that the title compound displays excellent antiproliferative activity against two human cancer cell lines. 展开更多
关键词 flavonoid 1 2 4-triazolo[1 5-a]pyrimidine single-crystal X-ray diffraction crystal structure SYNTHESIS antiproliferative activity
下载PDF
药物中间体5-溴-2-氯-N-环戊胺嘧啶-4-胺的有关物质含量分析方法
13
作者 柳毅 张卫 +1 位作者 王文标 高军龙 《广州化工》 CAS 2023年第21期85-87,共3页
建立了5-溴-2-氯-N-环戊胺嘧啶-4-胺高效液相色谱法测定有关物质含量的分析方法。以自身对照,按外标法加校正因子计算有关物质含量。使用Agilent HC-C18色谱柱,流动相为0.1%磷酸和乙腈,梯度洗脱;检测波长240 nm。各杂质在0.025~1.000μg... 建立了5-溴-2-氯-N-环戊胺嘧啶-4-胺高效液相色谱法测定有关物质含量的分析方法。以自身对照,按外标法加校正因子计算有关物质含量。使用Agilent HC-C18色谱柱,流动相为0.1%磷酸和乙腈,梯度洗脱;检测波长240 nm。各杂质在0.025~1.000μg/mL浓度范围内线性关系良好,平均加样回收率在90%~110%,其RSD小于5%。该方法快速、准确,适用于5-溴-2-氯-N-环戊胺嘧啶-4-胺有关物质含量分析方法的检测。 展开更多
关键词 5-溴-2-氯-N-环戊胺嘧啶-4-胺 高效液相色谱 自身对照 校正因子
下载PDF
结直肠癌患者DPYD基因多态性与5-FU毒性反应相关的Meta分析 被引量:10
14
作者 王勇 徐曦 王慧 《山东医药》 CAS 2014年第41期18-21,共4页
目的探讨结直肠癌患者二氢嘧啶脱氢酶(DPYD)基因多态性与5-氟尿嘧啶(5-FU)代谢及化疗后毒性反应的关系。方法参照Cochrance协作网制定的检索策略进行检索,电子数据库包括:MEDLINE(1966~2013),the Cochrane Library Database(Iss... 目的探讨结直肠癌患者二氢嘧啶脱氢酶(DPYD)基因多态性与5-氟尿嘧啶(5-FU)代谢及化疗后毒性反应的关系。方法参照Cochrance协作网制定的检索策略进行检索,电子数据库包括:MEDLINE(1966~2013),the Cochrane Library Database(Issue 12,2013),EMBASE(1980~2013),CINAHL(1982~2013),Web of Science(1945~2013),中国生物医学文献数据库(1982~2013),万方(1998~2013)和中国知网(1915~2013)。Meta分析采用Stata 12.0(Stata Corp,College Station,TX,USA)统计软件进行。结果本Meta分析共计纳入7项队列研究,包括946例结直肠癌患者。DPYD基因多态性与结直肠癌患者的骨髓抑制高发生率、胃肠道反应和手足综合征显著相关(P均〈0.05)。根据DPYD基因多态位点的不同进行亚组分析发现,IVS14+1、464T〉A和2194G〉A多态性与接受5-FU化疗的结直肠癌患者骨髓抑制发生率显著相关(P均〈0.05)。IVS14+1、496A〉G和2194G〉A多态性与胃肠道反应的发生率相关(P均〈0.05)。进一步根据种族不同进行亚组分析结果表明,DPYD基因多态性可能与亚洲人群骨髓抑制和胃肠道反应有关(P均〈0.05),但在欧洲人群中并没有此现象发生(P〉0.05)。结论DPYD基因多态性可能与亚洲人群中结直肠癌患者体内5-FU化疗后毒性反应有关。 展开更多
关键词 结直肠肿瘤 二氢嘧啶脱氢酶 基因多态性 5-氟尿嘧啶 META分析
下载PDF
5,6,7,8-四氢吡啶并[3,4-d]嘧啶衍生物的合成 被引量:11
15
作者 李世宁 孙春玲 +2 位作者 张丹丹 毛龙飞 王伟 《化学研究与应用》 CAS CSCD 北大核心 2016年第2期164-169,共6页
以苄胺为原料,经过取代,缩合,水解,脱保护等步骤,设计合成了一系列新型的5,6,7,8-四氢吡啶并[3,4-d]嘧啶类化合物。通过1H NMR,13C NMR,MS和元素分析确证了其结构。并且对其体外抗肿瘤活性进行了研究,发现该类化合物对乳腺癌细胞MCF-7... 以苄胺为原料,经过取代,缩合,水解,脱保护等步骤,设计合成了一系列新型的5,6,7,8-四氢吡啶并[3,4-d]嘧啶类化合物。通过1H NMR,13C NMR,MS和元素分析确证了其结构。并且对其体外抗肿瘤活性进行了研究,发现该类化合物对乳腺癌细胞MCF-7具有一定的抑制活性,其中化合物10a和10d的抑制活性达到了中效水平。 展开更多
关键词 5 6 7 8-四氢吡啶并[3 4-d]嘧啶 衍生物 合成 抗肿瘤
下载PDF
吡唑并[1,5-a]嘧啶类化合物的合成及其抗肿瘤活性 被引量:8
16
作者 李娟 赵燕芳 +2 位作者 陈栋 贾薇 宫平 《中国药物化学杂志》 CAS CSCD 2006年第6期352-355,共4页
目的设计合成新的吡唑并[1,5-a]嘧啶类化合物,并评价其抗肿瘤活性。方法根据吡唑并[1,5-a]嘧啶类抗肿瘤药物的基本结构设计了一系列5-胺甲基-7-苯胺基吡唑并[1,5-a]嘧啶类化合物,并以丙二腈和原甲酸三乙酯为起始原料,经5步反应得到目标... 目的设计合成新的吡唑并[1,5-a]嘧啶类化合物,并评价其抗肿瘤活性。方法根据吡唑并[1,5-a]嘧啶类抗肿瘤药物的基本结构设计了一系列5-胺甲基-7-苯胺基吡唑并[1,5-a]嘧啶类化合物,并以丙二腈和原甲酸三乙酯为起始原料,经5步反应得到目标产物。采用MTT法,以顺铂为阳性对照药,以Bel-7402和HT-1080为测试细胞株对目标化合物的抗肿瘤活性进行评价。结果与结论合成了11个未见文献报道的化合物,结构经质谱和核磁共振氢谱确证。化合物6显示出很好的抗肿瘤活性。 展开更多
关键词 药物化学 化合物制备 化学合成 吡唑并[1 5-α]嘧啶类化合物 抗肿瘤活性
下载PDF
4,6-双(5-氨基-3-硝基-1V,2,4-三唑-1-基)-5-硝基嘧啶(DANTNP)合成工艺改进 被引量:7
17
作者 贾思媛 王锡杰 +2 位作者 王伯周 张海昊 熊存良 《含能材料》 EI CAS CSCD 2008年第3期251-253,共3页
以5-氨基-3-硝基-1,2,4-三唑(ANTA)与4,6-二氯-5-硝基嘧啶(DCNP)为原料,在乙醇介质中进行亲核取代反应合成了4,6-双-(5-氨基-3-硝基-1,2,4-三唑-1-基)-5-硝基嘧啶(DANTNP),采用红外光谱、核磁共振、质谱、元素分析等鉴定其结构;同时,对... 以5-氨基-3-硝基-1,2,4-三唑(ANTA)与4,6-二氯-5-硝基嘧啶(DCNP)为原料,在乙醇介质中进行亲核取代反应合成了4,6-双-(5-氨基-3-硝基-1,2,4-三唑-1-基)-5-硝基嘧啶(DANTNP),采用红外光谱、核磁共振、质谱、元素分析等鉴定其结构;同时,对反应条件进行了优化(反应时间为6 h;CH3ONa:ANTA:DCNP的摩尔比为2.64:2.4:1,反应收率为68%;在体系中加入相转移催化剂18-冠-6-醚后,反应收率达到84%。 展开更多
关键词 有机化学 4 6-双(5-氨基-3-硝基-1 2 4-三唑-1-基)-5-硝基嘧啶(DANTNP) 合成 18-冠石一醚
下载PDF
测定人红细胞嘧啶5′核苷酸酶含量的双抗体夹心ELISA方法 被引量:2
18
作者 潘竹林 沈茜 +5 位作者 李津婴 闵碧荷 顾定伟 许小平 李红梅 张娴 《中国实验血液学杂志》 CAS CSCD 2001年第4期368-371,共4页
为了进一步探讨嘧啶 5′核苷酸酶 (P5′N)缺乏症的发病机制 ,我们利用P5′N的特异性底物尿苷一磷酸 (UMP)作为配基 ,制备尿苷一磷酸 己二酰肼 琼脂糖 4B(UMP ADH Sepharose 4B)亲和层析柱 ,结合硫酸铵分级分离和沉淀、离子层析及亲和... 为了进一步探讨嘧啶 5′核苷酸酶 (P5′N)缺乏症的发病机制 ,我们利用P5′N的特异性底物尿苷一磷酸 (UMP)作为配基 ,制备尿苷一磷酸 己二酰肼 琼脂糖 4B(UMP ADH Sepharose 4B)亲和层析柱 ,结合硫酸铵分级分离和沉淀、离子层析及亲和层析等方法提纯人红细胞P5′N。将所得P5′N免疫家兔 ,获得兔抗人抗体。以兔抗人P5′N抗体为包被抗体 ,辣根过氧化物酶 (HRP) 兔抗人P5′N抗体为显示抗体 ,经方阵法、抗原阻断试验及抗原替代试验后 ,建立定量测定人红细胞的P5′N双抗体夹心酶联免疫吸附实验。实验结果显示 ,所得兔抗人红细胞P5′N抗体效价为 1∶4 ,所建双抗体夹心ELISA法灵敏度为 5ng ml,其阻断率大于 95 %,而取代率小于 30 %。同时 ,测定正常人红细胞P5′N含量为 (71.77± 10 .98)ng mgNHP。该法特异性强 ,敏感性高 ,可检测最低含量为 5 - 2 0ng ml的P5′N含量 ,在临床上能适应大样本测定。 展开更多
关键词 嘧啶5′核苷酸酶 双抗体夹心ELISA 红细胞
下载PDF
新型2-甲基-5-羟基-7-氨基-吡唑[1,5-a]并嘧啶衍生物的合成 被引量:3
19
作者 周南 陈朝军 +2 位作者 鲁源 武世奎 王荣雁 《合成化学》 CAS CSCD 2016年第5期406-408,共3页
以3-甲基-5-氨基-吡唑和氰乙酸乙酯为原料,合成了2-甲基-5-羟基-7-氨基-吡唑[1,5-a]并嘧啶(2);2与芳胺的重氮盐溶液反应,合成了7个新型的2-甲基-5-羟基-6-芳基偶氮-7-亚氨基-吡唑[1,5-a]并嘧啶衍生物,收率87%~93%,其结构经~1H NMR,IR和E... 以3-甲基-5-氨基-吡唑和氰乙酸乙酯为原料,合成了2-甲基-5-羟基-7-氨基-吡唑[1,5-a]并嘧啶(2);2与芳胺的重氮盐溶液反应,合成了7个新型的2-甲基-5-羟基-6-芳基偶氮-7-亚氨基-吡唑[1,5-a]并嘧啶衍生物,收率87%~93%,其结构经~1H NMR,IR和ESI-MS表征。 展开更多
关键词 3-甲基-5-氨基-吡唑 氰乙酸乙酯 2-甲基-5-羟基-7-氨基-吡唑[1 5-a]并嘧啶衍生物 合成
下载PDF
5-氟尿嘧啶关节腔注射治疗膝骨关节炎伴关节积液30例临床研究 被引量:3
20
作者 柳霞 张弘 李柱 《中国医药导报》 CAS 2012年第31期63-64,67,共3页
目的探讨5-氟尿嘧啶(5-Flurouracil,5-Fu)关节腔注射治疗膝骨性关节炎伴关节积液的临床疗效。方法将60例膝骨性关节炎伴关节积液患者随机分为治疗组(30例)及对照组(30例),分别给予5-Fu和透明质酸钠(sodiumhyaluronate,SH)关节腔内注射,... 目的探讨5-氟尿嘧啶(5-Flurouracil,5-Fu)关节腔注射治疗膝骨性关节炎伴关节积液的临床疗效。方法将60例膝骨性关节炎伴关节积液患者随机分为治疗组(30例)及对照组(30例),分别给予5-Fu和透明质酸钠(sodiumhyaluronate,SH)关节腔内注射,每周1次,连续4次为1个疗程。两组均经1个疗程的治疗后,比较疗效。结果治疗组和对照组的有效率分别是96.7%和83.3%,差异有统计学意义(P<0.05),治疗组疗效优于对照组。结论 5-Fu治疗膝骨性关节炎伴关节积液有较好的临床疗效,明显优于透明质酸钠治疗。 展开更多
关键词 5-氟尿嘧啶 膝骨性关节炎 关节积液
下载PDF
上一页 1 2 8 下一页 到第
使用帮助 返回顶部